17
Participants
Start Date
September 2, 2008
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Decitabine
Starting dose of 10mg/m\^2 given daily via intravenous infusion on days 1-5 of 28 day cycle.
Pegylated Interferon Alpha-2b
Starting dose of 3 µg/kg injection under the skin once a week on days 1, 8, 15, and 21 of 28 day cycle.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Schering-Plough
INDUSTRY
Eisai Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER